AACR 2016 Poster: Clinical Pharmacokinetics and Pharmacodynamics of ME-401
26 October 2017
Overview
Clinical Pharmacokinetics and Pharmacodynamics of ME-401, an Oral, Potent and Selective Inhibitor of Phosphatidylinositol 3-Kinase P110δ, Following Single Ascending Dose Administration to Healthy Volunteers. Download our scientific poster titled, 'Clinical Pharmacokinetics and Pharmacodynamics of ME-401' from AACR 2016.